DADATA·ANALYSIS
FREE
company · cik 1347178

Vanda Pharmaceuticals Inc.

VNDANasdaqSIC 2834public
financials · annual · usd2026
Revenue$216.1M
Net income-$220.5M
Total assets$488.9M
Total liabilities$161.8M
Equity$327.2M
Operating cash-$109.4M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts2